His patents and prior research on liposomal carrier nanoparticles will be used for any and everything. Once the drug is developed (either "water loving" or "or "water hating"), they can be added to the liposome and the liposome targeted to region of interest.
Some of the recent published works that cited Michael W. Fountain utilizing his Liposome technology/research that he helped pioneer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.